VANCOUVER, BC, June 24, 2024 /PRNewswire/ — Steelhead LNG, a Vancouver-based developer in the liquefied natural gas (LNG) industry, proudly announces the recent award of patents in the United States and South Korea in relation to its proprietary near-shore floating LNG production facility system. These patents, granted based on Steelhead LNG’s years of proprietary advancements, […]
Category Archives: Pr Newswire
BEIJING, June 23, 2024 /PRNewswire/ — It’s a tremendous honor to receive the China International Science and Technology Cooperation Award. We pay high tribute to those honorees who have made important contributions to scientific and technological advancements. Let’s look forward to seeing who will be awarded this honor this year. Science and Technology Daily: […]
BEIJING and BRIDGEWATER, N.J., June 23, 2024 /PRNewswire/ — Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the results of the Phase 1b/2a clinical study of the Company’s independently developed glucagon-like peptide-1 (GLP-1) receptor agonist, GZR18 Injection, in an obese/overweight population in China, along with the results of two other innovative insulins’ […]
Pr Newswire
Novo Nordisk A/S: Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A
23
Jun
Jun
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had no prior prophylaxis treatment, experienced zero treated bleeds while on Mim8 Bagsværd, Denmark, 23 June 2024 – Novo Nordisk announced results from the phase 3 FRONTIER2 trial of 254 adults and adolescents aged 12 years and over with haemophilia A, with […]
DONGGUAN, China, June 23, 2024 /PRNewswire/ — Huawei Consumer Cloud Services and Malaysia Airlines have decided to enter a strategic partnership in penetrating Chinese Outbound Travel market. This highly anticipated collaboration was officially announced during the signing ceremony at Huawei’s 2024 Developer Conference. This historic moment was held at the Huawei Developer Conference 2024, adding […]
DONGGUAN, China, June 23, 2024 /PRNewswire/ — At the Huawei Developer Conference 2024 (HDC 2024), Huawei Consumer Cloud Services and Singapore-based Electric Mobility Company, Voltality Pte. Ltd (referred to as: Voltality), have agreed on a comprehensive cooperation agreement. Leveraging each party’s rich and precise data resources in their respective fields, this collaboration aims to continuously […]
DONGGUAN, China, June 23, 2024 /PRNewswire/ — At the Huawei Developer Conference 2024 (HDC 2024), Huawei Consumer Cloud Services and Singapore-based Electric Mobility Company, Voltality Pte. Ltd (referred to as: Voltality), have agreed on a comprehensive cooperation agreement. Leveraging each party’s rich and precise data resources in their respective fields, this collaboration aims to continuously […]
DONGGUAN, China, June 23, 2024 /PRNewswire/ — At the Huawei Developer Conference 2024 (HDC 2024), Huawei Consumer Cloud Services and Singapore-based Electric Mobility Company, Voltality Pte. Ltd (referred to as: Voltality), have agreed on a comprehensive cooperation agreement. Leveraging each party’s rich and precise data resources in their respective fields, this collaboration aims to continuously […]
NEW YORK, June 21, 2024 /PRNewswire/ — As the summer holiday approaches and families plan their outdoor adventures, the Air Pump Master is here to solve the common issue of inflating various equipment. Whether you’re driving to the beach, setting up a camp by the river, cycling, playing beach ball games, stand-up paddling, kayaking, or […]
Pr Newswire
Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
23
Jun
Jun
Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and cardiovascular disease risk GAITHERSBURG, Md., June 22, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today presented data on the effect of pemvidutide, its GLP-1/glucagon dual receptor agonist candidate in development for obesity and metabolic dysfunction-associated steatohepatitis […]